glp-1/gip agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GLP-1 Receptor Agonists Explained for
Description
However, the answer may lie in the location and metabolic activity of the excessive adipose tissue in these patients
Effect of 6week course of glucagonlike peptide 1 on glycaemic control, insulin sensitivity, and betacell function in type 2 diabetes: A parallelgroup study
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review
Further a trend towards a postoperative decline until POD1 was present in both, but 3.2-times more pronounced in patients who developed PHLF (p = 0.027) (Fig
